Dualyx Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Out of Business

  • Employees
  • 8

Employees

  • Latest Deal Type
  • Liquidation

Dualyx General Information

Description

Developer of immune modulators designed to provide a cure for autoimmune diseases. The company develops Treg-targeted therapies to suppress unwanted autoimmune reactions in autoimmune disease patients, enabling medical professionals to cure patients with lasting treatments.

Contact Information

Website
www.dualyx.com
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • Technologiepark 94
  • Zwijnaarde
  • 9052 Ghent
  • Belgium
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Life Sciences
Corporate Office
  • Technologiepark 94
  • Zwijnaarde
  • 9052 Ghent
  • Belgium

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Dualyx Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Bankruptcy: Liquidation 17-Nov-2025 Completed Bankruptcy: Liquidation
3. Early Stage VC (Series A) 15-May-2023 Completed Pre-Clinical Trials
2. Seed Round 20-Oct-2021 $4.3M $7.96M Completed Pre-Clinical Trials
1. Seed Round 31-Mar-2020 $3.65M $3.65M Completed Pre-Clinical Trials
To view Dualyx’s complete valuation and funding history, request access »

Dualyx Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A
Seed
To view Dualyx’s complete cap table history, request access »

Dualyx Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of immune modulators designed to provide a cure for autoimmune diseases. The company develops Treg-targeted th
Drug Discovery
Ghent, Belgium
8 As of 2024

Canterbury, United Kingdom
 

Gaithersburg, MD
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Dualyx Competitors (3)

One of Dualyx’s 3 competitors is Azadyne, a Venture Capital-Backed company based in Canterbury, United Kingdom.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Azadyne Venture Capital-Backed Canterbury, United Kingdom
Revolo Biotherapeutics Venture Capital-Backed Gaithersburg, MD
Maxion Therapeutics Venture Capital-Backed London, United Kingdom
You’re viewing 3 of 3 competitors. Get the full list »

Dualyx Patents

  • 7

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 1

    Pending

  • Expiring in next 12 mo

Dualyx Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-202210679-D0 Binding molecules targeting il-12rb2 Inactive 21-Jul-2022
WO-2024018241-A1 Binding molecules targeting il-12rb2 Inactive 21-Jul-2022
GB-202210680-D0 Binding molecules targeting il-35r Inactive 21-Jul-2022
WO-2024018242-A1 Binding molecules targeting il-35r Inactive 21-Jul-2022
GB-202115122-D0 Binding molecules targeting il-2 receptor Inactive 21-Oct-2021 C07K16/2866
To view Dualyx’s complete patent history, request access »

Dualyx Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ready to get started?

Request a free trial

Dualyx FAQs

  • When was Dualyx founded?

    Dualyx was founded in 2019.

  • Where is Dualyx headquartered?

    Dualyx is headquartered in Ghent, Belgium.

  • What is the size of Dualyx?

    Dualyx has 8 total employees.

  • What industry is Dualyx in?

    Dualyx’s primary industry is Drug Discovery.

  • Is Dualyx a private or public company?

    Dualyx is a Private company.

  • What is Dualyx’s current revenue?

    The current revenue for Dualyx is .

  • How much funding has Dualyx raised over time?

    Dualyx has raised $54.6M.

  • Who are Dualyx’s competitors?

    Azadyne, Revolo Biotherapeutics, and Maxion Therapeutics are competitors of Dualyx.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process